{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2015"],"condition":["Metastatic Colorectal Cancer","Colorectal cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2191693"],"location":["United States"],"study_start_month":["3"],"keyword":["Colorectal adenocarcinoma"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Regorafenib in Metastatic Colorectal Cancer","description":"The purpose of the study is to measure high grade (3-5) toxicity of regorafenib and to monitor the impact of treatment with regorafenib on the quality of life in older adults with metastatic colorectal cancer.","dates":{"creation":"2015-03-15"},"accession":"2191693","cross_references":{"ClinicalTrials___gov":["NCT02466009"]}}